We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

176 hedge funds and large institutions have $1.03B invested in Emergent Biosolutions in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 67

0.81% less ownership

Funds ownership: 88.25% → 87.44% (-0.81%)

12% less capital invested

Capital invested by funds: $1.17B → $1.03B (-$140M)

15% less funds holding

Funds holding: 208 → 176 (-32)

35% less call options, than puts

Call options by funds: $370K | Put options by funds: $568K

63% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 40

Holders
176
Holders Change
-32
Holders Change %
-15.38%
% of All Funds
4.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
71
Reduced
67
Closed
40
Calls
$370K
Puts
$568K
Net Calls
-$198K
Net Calls Change
-$711K

Top Buyers

1
BlackRock
BlackRock
New York
+$128M
2
Millennium Management
Millennium Management
New York
+$16.7M
3
AAM
Aberdeen Asset Management
United Kingdom
+$11.3M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$8.84M
5
GT
Glenmede Trust
Pennsylvania
+$7.75M

Top Sellers

1
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
-$16M
2
Goldman Sachs
Goldman Sachs
New York
-$12.9M
3
PRCM
Pine River Capital Management
Minnesota
-$9.33M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.75M
5
LCP
Lombardia Capital Partners
California
-$7.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$122M +$128M +4,198,203 +137,736%
Vanguard Group
2
Vanguard Group
Pennsylvania
$110M +$7.25M +238,194 +7%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$59.6M +$863K +28,365 +1%
GT
4
Glenmede Trust
Pennsylvania
$50M +$7.75M +254,633 +17%
AAM
5
Aberdeen Asset Management
United Kingdom
$47M +$11.3M +369,908 +30%
State Street
6
State Street
Massachusetts
$42.2M +$6.5M +213,500 +17%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$40.7M +$570K +18,739 +1%
SCM
8
Snyder Capital Management
California
$32.9M +$5.22M +171,636 +18%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$27.3M +$5.32M +174,891 +23%
Renaissance Technologies
10
Renaissance Technologies
New York
$20.4M -$5.5M -180,800 -20%
Charles Schwab
11
Charles Schwab
California
$20.4M +$471K +15,478 +2%
Millennium Management
12
Millennium Management
New York
$20.2M +$16.7M +548,780 +376%
Fidelity International
13
Fidelity International
Bermuda
$19.5M -$1.65M -54,260 -7%
UBS AM
14
UBS AM
Illinois
$19.1M -$2.33M -76,444 -10%
LSV Asset Management
15
LSV Asset Management
Illinois
$18.1M +$2.39M +78,500 +14%
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$17.9M -$4.01M -131,583 -18%
Northern Trust
17
Northern Trust
Illinois
$17.9M +$562K +18,462 +3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$16.2M -$4.74M -155,631 -22%
RHJA
19
Rice Hall James & Associates
California
$15.4M +$4.29M +140,906 +36%
Russell Investments Group
20
Russell Investments Group
United Kingdom
$13.4M +$435K +14,295 +3%
Fisher Asset Management
21
Fisher Asset Management
Washington
$12M -$160K -5,250 -1%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$11.8M -$7.75M -254,486 -39%
GC
23
Guggenheim Capital
Illinois
$11.2M -$116K -3,813 -1%
Norges Bank
24
Norges Bank
Norway
$10.9M – – –
TA
25
Teachers Advisors
New York
$10.8M +$49.3K +1,618 +0.4%
1
2 3 4 5

EBS Hedge Fund Activity: Q1 2017 in Review

176 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2017, worth a combined $1.03B — down 12% from $1.17B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of EBS and 15 opened new positions — a net loss of 25 holders — while 67 trimmed existing stakes and 71 added.

The largest buyer was BlackRock, adding an estimated $128M. The largest seller was Mesirow Financial Investment Management - Fixed Income, exiting entirely with an estimated $16M sold.

  • 176 institutional investors held Emergent Biosolutions (EBS) as of Q1 2017, down from 208 in Q4 2016.
  • Funds reported $1.03B of Emergent Biosolutions stock for Q1 2017, down 12% quarter-over-quarter.
  • 15 funds opened new Emergent Biosolutions positions in Q1 2017 and 40 closed out, a net change of -25 holders.
  • The largest Emergent Biosolutions buyer in Q1 2017 was BlackRock, an estimated $128M added.
  • The largest Emergent Biosolutions seller in Q1 2017 was Mesirow Financial Investment Management - Fixed Income, an estimated $16M sold.

Based on aggregated 13F filings for Q1 2017.